Our Safety‑First Gene‑Therapy Platform
VECGEN is committed to providing cutting-edge safety solutions for gene therapy. Contact us today to explore our innovative services.
Predictive Analysis
Off-target risk modeling using genomic and transcriptomic insights
Safety Screening
In vitro and in vivo validation pipelines
Standards Reporting
Clear documentation for IND filings
Scalable & Flexible
Services tailored to early‑stage and advanced assets
About Our Visionary Team
At VECGEN, we are driven by a passion for excellence and a dedication to advancing gene therapy safety. Our team of scientists and industry veterans combine deep scientific expertise with innovative technologies to deliver world-class consulting services for gene therapy companies.
With a focus on safety, efficacy, and regulatory readiness, we partner with organizations at every stage of development—from preclinical studies to clinical trials and beyond. By blending cutting-edge molecular insights with strategic guidance, we help our clients navigate complex challenges and accelerate their path to market.
Meet Our Team
Co Founder
John Klich, PhD
Co Founder
Bradley Hamilton, PHD
Co Founder
Fraser Wright, PhD
How It Works
Discover & Profile
Comprehensive genomic and molecular profiling for target/off‑target mapping.
Predict & Optimize
Computational modeling to refine constructs and minimize risk.
Validate Safely
Custom in vitro and animal assays to confirm safety
Report & Monitor
Clear and comprehensive safety reports for confident decision-making.
Advancing Gene Therapy Safety
Our consulting experts are ready to help you navigate the complexities of gene therapy development with confidence.
Safety Overview
About Us
Team
How It Works
Contact
Privacy Policy
Terms and Conditions
© 2025 VECGEN, All rights reserved.